Related Experiment Video
Updated: May 1, 2026
06:04
Functional Near-Infrared Spectroscopy Hyperscanning Study in Psychological Counseling
Published on: January 17, 2025
1.7K
Online Group Hypnotherapy for Irritable Bowel Syndrome-a Pilot Study
Jenny Lövdahl1,2, Hans Törnblom1,2, Gisela Ringström1,2
1Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Neurogastroenterology and Motility
|April 30, 2026
Summary
Online group hypnotherapy for irritable bowel syndrome (IBS) is effective and preferred by patients. This nurse-led treatment is comparable to in-person sessions, increasing accessibility for IBS symptom management.
Area of Science:
- Gastroenterology
- Psychiatry
- Digital Health
Background:
- Gut-directed hypnotherapy is a proven IBS treatment.
- Group and nurse-led formats enhance accessibility.
- Online delivery shows promise but requires group format testing.
Purpose of the Study:
- Assess acceptability and efficacy of nurse-led, online group hypnotherapy for IBS.
- Compare online group outcomes to on-site delivery.
- Evaluate patient preference for treatment modality.
Main Methods:
- 51 IBS patients received 8 online group hypnotherapy sessions via video conferencing.
- Assessed IBS Severity Score (IBS-SSS), extracolonic/psychological symptoms, and quality of life.
- Evaluated usability, satisfaction, and compared results to on-site group hypnotherapy.
Main Results:
- Significant reduction in IBS severity (IBS-SSS) post-treatment (p < 0.001).
- 53% of patients were responders, comparable to on-site group hypnotherapy (55%).
- Symptom improvement sustained at 6-month follow-up; high usability and satisfaction reported.
Conclusions:
- Online nurse-led group hypnotherapy is acceptable and effective for IBS.
- Patients often prefer the online format.
- This approach enhances hypnotherapy accessibility for IBS patients.
More Related Videos
Related Concept Videos
01:23Irritable Bowel Syndrome
36
DefinitionIrritable bowel syndrome (IBS) is a functional gastrointestinal disorder characterized by recurrent combinations of abdominal pain, bloating, diarrhea, or constipation.Pathophysiology of irritable bowel syndromeIts pathophysiology is multifactorial, involving disturbances in motility, sensory processing, microbial balance, barrier integrity, and gut–brain communication. These mechanisms interact to produce symptoms that vary across IBS subtypes.Altered Motility...
36
01:17Irritable Bowel Syndrome I: Introduction
1.4K
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
1.4K
01:30Irritable Bowel Syndrome III: Medical and Nursing Management
989
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
989
01:30Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
1.0K
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
1.0K
01:17Drugs for Treatment of Diarrhea-Predominant IBS
1.0K
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
1.0K
01:21Drugs for Treatment of Constipation-Predominant IBS
1.4K
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
1.4K